DGX
Income statement / Annual
Last year (2024), Quest Diagnostics Incorporated's total revenue was $9.87 B,
an increase of 6.70% from the previous year.
In 2024, Quest Diagnostics Incorporated's net income was $871.00 M.
See Quest Diagnostics Incorporated,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$9.87 B |
$9.25 B |
$9.88 B |
$10.79 B |
$9.44 B |
$7.73 B |
$7.53 B |
$7.71 B |
$7.52 B |
$7.49 B |
| Cost of Revenue |
$6.63 B
|
$6.29 B
|
$6.45 B
|
$6.58 B
|
$5.80 B
|
$5.04 B
|
$4.93 B
|
$4.72 B
|
$4.62 B
|
$4.66 B
|
| Gross Profit |
$3.24 B
|
$2.96 B
|
$3.43 B
|
$4.21 B
|
$3.63 B
|
$2.69 B
|
$2.61 B
|
$2.99 B
|
$2.90 B
|
$2.84 B
|
| Gross Profit Ratio |
0.33
|
0.32
|
0.35
|
0.39
|
0.38
|
0.35
|
0.35
|
0.39
|
0.39
|
0.38
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.42 B
|
$1.75 B
|
$1.68 B
|
$1.68 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.77 B
|
$1.62 B
|
$1.87 B
|
$1.73 B
|
$1.55 B
|
$1.46 B
|
$1.42 B
|
$1.75 B
|
$1.68 B
|
$1.68 B
|
| Other Expenses |
$128.00 M
|
$0.00
|
$131.00 M
|
$101.00 M
|
$112.00 M
|
$1.00 M
|
-$8.00 M
|
$16.00 M
|
-$48.00 M
|
-$143.00 M
|
| Operating Expenses |
$1.93 B
|
$1.76 B
|
$2.01 B
|
$1.83 B
|
$1.66 B
|
$1.46 B
|
$1.50 B
|
$1.83 B
|
$1.74 B
|
$1.77 B
|
| Cost And Expenses |
$8.53 B
|
$7.99 B
|
$8.46 B
|
$8.41 B
|
$7.47 B
|
$6.50 B
|
$6.43 B
|
$6.54 B
|
$6.36 B
|
$6.43 B
|
| Interest Income |
$25.00 M
|
$11.00 M
|
$10.00 M
|
$1.00 M
|
$3.00 M
|
$5.00 M
|
$2.00 M
|
$2.00 M
|
$1.00 M
|
$1.00 M
|
| Interest Expense |
$226.00 M
|
$163.00 M
|
$138.00 M
|
$151.00 M
|
$163.00 M
|
$175.00 M
|
$167.00 M
|
$151.00 M
|
$143.00 M
|
$153.00 M
|
| Depreciation & Amortization |
$493.00 M
|
$439.00 M
|
$437.00 M
|
$408.00 M
|
$361.00 M
|
$329.00 M
|
$309.00 M
|
$270.00 M
|
$249.00 M
|
$304.00 M
|
| EBITDA |
$1.91 B |
$1.73 B |
$1.82 B |
$3.16 B |
$2.41 B |
$1.59 B |
$1.40 B |
$1.45 B |
$1.48 B |
$1.56 B |
| EBITDA Ratio |
0.19
|
0.19
|
0.18
|
0.29
|
0.26
|
0.2
|
0.19
|
0.19
|
0.18
|
0.21
|
| Operating Income Ratio |
0.14
|
0.14
|
0.14
|
0.22
|
0.21
|
0.16
|
0.15
|
0.15
|
0.17
|
0.19
|
| Total Other Income/Expenses Net |
-$171.00 M
|
-$132.00 M
|
-$193.00 M
|
$218.00 M
|
-$87.00 M
|
-$155.00 M
|
-$175.00 M
|
-$135.00 M
|
-$142.00 M
|
-$101.00 M
|
| Income Before Tax |
$1.18 B
|
$1.13 B
|
$1.24 B
|
$2.60 B
|
$1.88 B
|
$1.08 B
|
$926.00 M
|
$1.03 B
|
$1.09 B
|
$1.10 B
|
| Income Before Tax Ratio |
0.12
|
0.12
|
0.12
|
0.24
|
0.2
|
0.14
|
0.12
|
0.13
|
0.14
|
0.15
|
| Income Tax Expense |
$273.00 M
|
$248.00 M
|
$264.00 M
|
$597.00 M
|
$460.00 M
|
$247.00 M
|
$182.00 M
|
$241.00 M
|
$429.00 M
|
$373.00 M
|
| Net Income |
$871.00 M
|
$854.00 M
|
$946.00 M
|
$2.00 B
|
$1.43 B
|
$858.00 M
|
$736.00 M
|
$772.00 M
|
$645.00 M
|
$709.00 M
|
| Net Income Ratio |
0.09
|
0.09
|
0.1
|
0.18
|
0.15
|
0.11
|
0.1
|
0.1
|
0.09
|
0.09
|
| EPS |
7.8 |
7.59 |
8.12 |
15.9 |
10.68 |
6.38 |
5.41 |
5.63 |
4.58 |
4.92 |
| EPS Diluted |
7.66 |
7.52 |
7.98 |
15.53 |
10.52 |
6.29 |
5.29 |
5.5 |
4.51 |
4.87 |
| Weighted Average Shares Out |
$111.00 M
|
$112.00 M
|
$116.00 M
|
$125.00 M
|
$134.00 M
|
$134.00 M
|
$136.00 M
|
$137.00 M
|
$140.00 M
|
$144.00 M
|
| Weighted Average Shares Out Diluted |
$113.00 M
|
$113.00 M
|
$118.00 M
|
$128.00 M
|
$136.00 M
|
$136.00 M
|
$139.00 M
|
$140.00 M
|
$142.00 M
|
$145.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
